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PAYMENT CHANGES NECESSARY TO CATALYZE
HIGHER-QUALITY, LOWER-COST CARE
RAYmOND GIBBONS,

M.D., JEFFREY KoRSMo,* &

RoSHELLE PLUTOWSKIt

During the 2010 mid-term election campaign, the new
health care law-The Patient Protection and Affordable Care Act
(PPACA)'-continued to be hotly debated by both political parties. Three states voted on ballot measures that contested the
constitutionality of an individual mandate to buy health insurance. 2 A coalition of states called for the repeal of the law on the
grounds that the Medicaid expansion would impose a huge fiscal
burden on state budgets. 3 Interest groups began lobbying efforts
to change selected provisions.'
Vigorous civic debate reflecting multiple points of view is a
hallmark of a vibrant democracy. Some of the debate has been
authentic and productive. However, some public discourse on
health care reform has disintegrated into partisanship, fear
mongering, and finger pointing. It appears that we Americans
and our elected officials have not yet agreed on the fundamental
goal of health care reform and how to develop policies that will
support it.
Nearly six years ago, Mayo Clinic became more publicly
engaged in the health care reform debate because a confluence
*
Dr. Gibbons and Jeffrey Korsmo are both senior leaders at Mayo Clinic
and have collaborated on health care reform efforts through the Mayo Clinic
Health Policy Center.
f Mayo Clinic Health Policy Center. The authors thank Shelly Plutowski
for her editorial contributions to this manuscript.
1. Patient Protection and Affordable Care Act, Pub. L. No. 111-148, 124
Stat. 119 (2010) (to be codified as amended in scattered sections of 25 U.S.C.,
26 U.S.C., 29 U.S.C., and 42 U.S.C.) [hereinafter PPACA]. For ease of reference, PPACA as used here also includes amendments made to it by the Health
Care and Education Reconciliation Act of 2010, Pub. L. No. 111-152, 124 Stat.
1029.
2. See Julian Pecquet, Midterm Voters in Three States Will Cast Ballots on
HealthcareInsurance Mandate, THE HILL (Nov. 1, 2010, 12:36 PM ET), http://
thehill.com/blogs/healthwatch/politics-elections/126801-states-hold-referendums-on-individual-mandate.
3. See Rick Schmitt, Suits Over Health Care Law Heat Up, USA TODAY, Oct.
6, 2010, at lB.
4. See Dan Eggen, ForMany Interest Groups, Health-CareBill's PassageDoesn't
Stop the Fight, WASH. Posr, Mar. 24, 2010, at A05.
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of issues pointed to serious trouble ahead: increasing numbers of
uninsured, uneven health care quality and safety throughout the
country, skyrocketing costs, and an impending explosion of babyboomers reaching Medicare age. Through the efforts of our
non-partisan Mayo Clinic Health Policy Center, thousands of
patients, providers, academics, medical industry leaders, employers, insurers, and policy makers have come together to develop
and advocate for four cornerstones of reform: create value, coordinate care, reform the payment system, and provide health
insurance for all. These principles reflect a shared vision: quality, affordable health care for all Americans. We call this highvalue health care.
Throughout the debate on health care reform, Mayo Clinic
used these four cornerstones as standards against which to evaluate legislative proposals. Even though we did not take a formal
position regarding the final legislation, we continued to articulate our areas of agreement and areas of concern with PPACA.
We believe that some PPACA provisions are aligned in principle with our cornerstones for reform, such as:
* Insurance reforms, including an individual mandate to
buy insurance and the elimination of exclusions for
pre-existing conditions.
* Subsidies for people who need financial help to
purchase health insurance.
* Accountable care, medical homes, and bundled payments as alternatives to better coordinate care and
lower costs.
At the same time, we expressed significant concern with
some of the financing and cost-containment elements of the law,
including:
* Across-the-board provider cuts, which punish the good
and bad equally.
* The timeline and scope for studying and implementing
new payment models.
Although the law does take some first steps to reward doctors and hospitals that deliver value-better health care outcomes at lower costs-these provisions are not comprehensive or
aggressive enough to have an immediate impact on lowering
costs and improving quality. Much stronger provisions are
required to change the trajectory of American health care.
Current fee-for-service reimbursement schemes reward medical piecework-performing diagnostic tests, procedures, and
surgeries. It is therefore not surprising that U.S. health care is
dominated by such costly services. Each year, Medicare issues its

2011]1

PAYMENT CHANGES NECESSARY

395

annual payment rate update rules for thousands of services in
hundreds of geographic regions. The complex payment formula
includes physician work, practice expense, malpractice expense,
geographic cost variations, and a conversion factor that has been
adjusted to ensure budget neutrality. Through its focus on payment per service, this seriously flawed approach promotes
overuse of procedures and fuels rising health care costs. Doctors
are financially rewarded for doing more, not for providing quality,
affordable health care.
In his widely cited New Yorker essay "The Cost Conundrum,"
Atul Gawande, M.D., tells the tale of two Texas cities of similar
size, location, and demographics-El Paso and McAllen-which
have substantially different annual costs for Medicare beneficiaries. In 2006, McAllen cost Medicare $14,946 per enrollee,
while El Paso cost about half of that-$7,504 per enrollee.
Gawande's initial premise was that the quality of care in McAllen
must be superior, but further review of delivery system performance disproved this theory. He concluded:
Analysis of Medicare data by the Dartmouth Atlas project
shows the difference is due to marked differences in the
amount of care ordered for patients-patients in McAllen
receive vastly more diagnostic tests, hospital admissions,
operations, specialist visits, and home nursing care than in
El Paso. But quality of care in McAllen is not appreciably
better, and by some measures, it is worse.

..

. [T]he care

for patients in the highest-cost regions of the country tends

to go this way-with more high-cost care across the board,
but less low-cost preventive services and primary care, and
equal or worse survival, functional ability, and satisfaction

with care ... 6
Believing that more care is better, individual patients sometimes contribute to the problem of overutilization by demanding
services from their doctors. However, research supports a
counter-intuitive mantra: less is often better when it comes to
health care. For example, two cardiology studies have found that
less expensive drug therapy is just as effective at reducing future
cardiovascular events and death as heart bypass surgery or coronary artery stenting.' Bone marrow transplantation was widely
June 1, 2009, at 36.
(une 23,
2009), http://www.newyorker.com/online/blogs/newsdesk/2009/06/atulgawande-the-cost-conundrum-redux.html#ixzzl4uZkvVXL.
5.

Atul Gawande, The Cost Conundrum, NEW

6.

Atul Gawande, The Cost Conundrum Redux,

YORKER,

NEW YORKER

7. See BARI 2D Study Group, A Randomized Trial of Therapiesfor Type 2
Diabetes and Coronary Artery Disease, 360 NEW ENG. J. MED. 2503 (2009); William
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performed for women with breast cancer until studies showed
that it brought no benefit.' Research has also shown that using
less expensive generic drugs to treat high blood pressure is just as
effective as treatment with more expensive brand-name drugs.'
Too often, however, this new evidence does not make its way
quickly into practice, and overutilization of expensive therapies
continues. The country-individuals, employers, and our government-simply can't afford the status quo. The rising cost of
health care affects everyday Americans by reducing the amount
of money they have for other necessities, causing them persistent
financial stress. Making an effort to compete both locally and
globally, small and big businesses alike defer job creation and
business growth as they struggle to manage exploding health
care benefit costs. Meanwhile, state and federal governmentsattempting to balance shrinking budgets-reduce provider payments for public health insurance programs. In turn, hospitals
and doctors charge more to patients with commercial insurance,
are incentivized to reduce access to patients on public programs,
and boost the number of services they provide to mitigate the
cuts. Thus, costs rise while patient satisfaction and access
decline. American health care remains trapped in this downward
spiral.
How can we interrupt this deeply ingrained pattern? We
must take the critical first step to fundamentally realign the
financial incentives that drive the way care is delivered. We must
strengthen efforts to pay for the desired result: high-value health
care. Democrats and Republicans have expressed support for this
approach. Health and Human Services Secretary Kathleen Sebelius told the American Hospital Association that it is critical to
"change the incentives in our health care system so doctors and
hospitals get rewarded for delivering high quality care. ... [W] e
pay too often for quantity, not quality. For volume, not value.""o
Likewise, prominent Republican leader Bill Frist wrote in The
E. Boden et al., Optimal Medical Therapy with or without PCIfor Stable Coronary
Coronary Disease, 356 NEw ENG. J. MED. 1503 (2007).
8. See Edward A. Stadtmauer et al., Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantationfor Metastatic Breast Cancer, 342 NEW ENG. J. MED. 1069 (2000).
9. See ALLHAT Officers and Coordinators for the ALLHAT Collaborative
Research Group, Major Outcomes in High-Risk Hypertensive PatientsRandomized to
Angiotensin-ConvertingEnzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
(ALLHAT), 288 JAMA 2981 (2002).
10. Kathleen Sebelius, Address to the American Hospital Association
(Apr. 26, 2010), available at http://www.troncommunications.com/Produc
tions/kathleensebelius.wmv.
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New York Times that "[t]he most powerful way to reduce costs
(and make room to expand coverage) is to shift away from 'volume-based' reimbursement (the more you do, the more money
you make) to 'value-based' reimbursement.""
We recommend that Congress set a five-year deadline for
creating and implementing new Medicare payment methods,
using a mechanism within PPACA-The Center for Medicare
This new office is tasked with
and Medicaid Innovation (CMI).
researching, developing, testing, and expanding innovative payment models and care delivery arrangements to improve value
for patients enrolled in each federal program. One approach
would be for Medicare to establish new value-based payment
methods for the most expensive three to five conditions and procedures-sending providers the message that they must begin reengineering care delivery to create higher quality, lower-cost care
for patients. Another approach would be to base a portion of
Medicare payments on value, rewarding those who offer highquality, affordable care and providing an incentive for others to
improve. (Data are currently available to measure and compare
providers' performance.)'" Over time, we believe that health
care professionals would change key behaviors-for example,
sharing information and eliminating unnecessary tests-that
would lead to better, less-expensive care.
Unfortunately, efforts to provide high-value care are frequently penalized by the existing reimbursement system. Seattlebased Virginia Mason Medical Center (VMC) took a fresh
approach to this problem by working with Aetna and several big
regional employers to redesign how providers treated patients
with common, expensive medical problems such as migraine and
back pain. 4 As the groups worked to standardize the carethrough same day access and evidence-based care that reduced
the number of expensive tests and specialist visits-the costs for
purchasers went down quickly, but the medical center also lost
money. For example, each avoided MRI saved the purchasers
about $850, while VMC lost about $450 in profit. Working
together, the group realigned reimbursement-increasing payments for physical therapy sessions, for example-so that the
11. Bill Frist, Op-Ed., How the G.O.P. Can Fix Health Care, N.Y. TIMES, Feb.
22, 2010, at A19.
12. PPACA, Pub. L. No. 111-148, § 3021, 124 Stat. 119, 262 (2010).
13. See Robert K. Smoldt & Denis A. Cortese, Pay-for-Performanceor Payfor
Value?, 82 MAYO CLINIC PRoc. 210 (2007).
14. Vanessa Fuhrmans, A Novel Plan Helps Hospital Wean Itself Off Pricey
Tests, WALL ST. J., Jan. 12, 2007, at Al.
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medical center could break even or make a small profit on the
higher-value care they were providing.
Moving forward, we must ensure that health care in the
United States is patient-centered, coordinated, accessible, affordable, and that it provides better value-whether that care is provided under Medicare or any other insurance program. It is time
for health care providers to take a leadership role in creating
high-value care that will yield affordable insurance, lower health
care costs, and better health for the people of our nation. The
challenge for providers is two-fold: Do the right thing, and do the
thing right. Insurers must reward these efforts and remove the
perverse incentives that favor more tests and procedures in the
existing system. Patients must learn that more care is not necessarily better and take greater responsibility for their own health
by making lifestyle changes to prevent disease. The challenges
are daunting, as meaningful reform requires painful changes by
nearly everyone, but our nation can no longer afford the status
quo.

